Covid-19 Vaccine Effectiveness against the Omicron (B.1.1.529) Variant.

Andrews, Nick; Stowe, Julia; Kirsebom, Freja; Toffa, Samuel; Rickeard, Tim; Gallagher, Eileen; Gower, Charlotte; Kall, Meaghan; Groves, Natalie; O'Connell, Anne-Marie; +21 more... Simons, David; Blomquist, Paula B; Zaidi, Asad; Nash, Sophie; Iwani Binti Abdul Aziz, Nurin; Thelwall, Simon; Dabrera, Gavin; Myers, Richard; Amirthalingam, Gayatri; Gharbia, Saheer; Barrett, Jeffrey C; Elson, Richard; Ladhani, Shamez N; Ferguson, Neil; Zambon, Maria; Campbell, Colin NJ; Brown, Kevin; Hopkins, Susan; Chand, Meera; Ramsay, Mary; Lopez Bernal, Jamie; (2022) Covid-19 Vaccine Effectiveness against the Omicron (B.1.1.529) Variant. New England Journal of Medicine, 386 (16). pp. 1532-1546. ISSN 0028-4793 DOI: https://doi.org/10.1056/NEJMoa2119451

Permanent Identifier

Use this Digital Object Identifier when citing or linking to this resource.

https://doi.org/10.1056/NEJMoa2119451

Abstract

Item Type Article
Research Centre Covid-19 Research
PubMed ID 35249272
Elements ID 172617

Share

Download

Filename: Covid-19 Vaccine Effectiveness against the Omicron (B.1.1.529) Variant.pdf

Licence: Copyright the publishers

Download
[img]

Downloads

View details

Metrics & Citations


Google Scholar